Patents by Inventor Christopher Lum

Christopher Lum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250383220
    Abstract: The disclosure includes vehicle-mounting devices to mount one or more utility locator devices to a vehicle for use in locating and mapping buried utility lines. Such vehicle-mounting devices may improve over other vehicle-mounting devices known in the art by preventing damage to associated utility locator devices as well as the vehicle mounting device. Further, such devices may be included in vehicle-based locate systems as well as in a computer implemented method for utility line positions and characteristics using Artificial Intelligence (AI).
    Type: Application
    Filed: June 11, 2025
    Publication date: December 18, 2025
    Inventors: Mark S. Olsson, Christopher Lum
  • Patent number: 7407952
    Abstract: Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed: wherein A, R1, R2, R2a and R3 are as defined herein. Such compounds have utility over a wide range of fields, including use as diagnostic and therapeutic agents. In particular, compounds of this invention are useful in pharmaceutical compositions as anti-inflammatory agents as well as inhibitors of central nervous disorders. Libraries containing the compounds of this invention are also disclosed, as well as methods for screening the same to identify biologically active members.
    Type: Grant
    Filed: July 6, 2005
    Date of Patent: August 5, 2008
    Assignee: Myriad Genetics, Inc.
    Inventors: Gangadhar Nagula, Jan Urban, Hwa-Ok Kim, Christopher Lum, Hiroshi Nakanishi
  • Publication number: 20070088163
    Abstract: In various aspects, the present invention relates to novel compounds, which modulate calcitonin and amylin receptor activity; to processes for the preparation of such compounds; and to pharmaceutical compositions including such compounds. Compounds of the invention are useful as calcitonin and/or amylin agonists and in the treatment of bone disease such as osteoporosis, Paget's disease, hypercalcemia, and in the treatment of metabolic diseases, such as insulin-requiring states.
    Type: Application
    Filed: September 10, 2004
    Publication date: April 19, 2007
    Inventors: Kent Pryor, Eddine Saiah, Jeffrey Kahl, Nancy Delaet, Edward Roberts, Jan Urban, Lubomir Sebo, Christopher Lum, Hiroshi Nakanishi
  • Publication number: 20050245528
    Abstract: Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed: wherein A, R1, R2, R2a and R3 are as defined herein. Such compounds have utility over a wide range of fields, including use as diagnostic and therapeutic agents. In particular, compounds of this invention are useful in pharmaceutical compositions as anti-inflammatory agents as well as inhibitors of central nervous disorders. Libraries containing the compounds of this invention are also disclosed, as well as methods for screening the same to identify biologically active members.
    Type: Application
    Filed: July 6, 2005
    Publication date: November 3, 2005
    Applicant: Myriad Genetics, Incorporated
    Inventors: Gangadhar Nagula, Jan Urban, Hwa-Ok Kim, Christopher Lum, Hiroshi Nakanishi
  • Patent number: 6943157
    Abstract: Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed: wherein A, R1, R2, R2a and R3 are as defined herein. Such compounds have utility over a wide range of fields, including use as diagnostic and therapeutic agents. In particular, compounds of this invention are useful in pharmaceutical compositions as anti-inflammatory agents as well as inhibitors of central nervous disorders. Libraries containing the compounds of this invention are also disclosed, as well as methods for screening the same to identify biologically active members.
    Type: Grant
    Filed: October 9, 2002
    Date of Patent: September 13, 2005
    Assignee: Myriad Genetics, Inc.
    Inventors: Gangadhar Nagula, Jan Urban, Hwa-Ok Kim, Christopher Lum, Hiroshi Nakanishi
  • Publication number: 20040248850
    Abstract: The present invention is related to compounds, their intermediates, processes for their preparation and use, and pharmaceutical compositions comprising the compounds. The novel compounds are useful in therapy, and in particular for the treatment of viral infection, particularly HIV infection.
    Type: Application
    Filed: February 6, 2004
    Publication date: December 9, 2004
    Applicant: Kemia, Inc.
    Inventors: Justin T. Ernst, Erik Boman, Susana C. Ceide, Antonio G. Montalban, Hiroshi Nakanishi, Edward Roberts, Eddine Saiah, Christopher Lum
  • Publication number: 20030220328
    Abstract: Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins having the following structure are disclosed: 1
    Type: Application
    Filed: October 9, 2002
    Publication date: November 27, 2003
    Applicant: Molecumetics Ltd.
    Inventors: Gangadhar Nagula, Jan Urban, Hwa-Ok Kim, Christopher Lum, Hiroshi Nakanishi